Insulin could reverse GDM-related endothelium abnormalities (109) via activation of insulin receptors (110), A1 adenosine receptors (109), and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (111). The gene discussed is INS; the disease is gestational diabetes.